What is Glycerol-3-phosphate acyltransferase (plsY) and what is its role in Salmonella dublin?

Glycerol-3-phosphate acyltransferase (plsY) is a crucial enzyme involved in phospholipid biosynthesis in bacteria. In Salmonella dublin, plsY (also known as ygiH or SeD_A3563) functions as a lysophosphatidic acid synthase that catalyzes the transfer of an acyl group to glycerol-3-phosphate, forming lysophosphatidic acid—a critical intermediate in membrane phospholipid synthesis . The enzyme is essential for bacterial membrane integrity and cellular function. The full-length protein consists of 203 amino acids and is encoded by the plsY gene in Salmonella dublin .

How is recombinant plsY typically expressed and purified for research purposes?

Recombinant Salmonella dublin plsY is typically expressed in E. coli expression systems with an N-terminal His-tag to facilitate purification. The protein can be expressed as a full-length construct (1-203 amino acids) and purified to >90% purity as determined by SDS-PAGE .

For optimal expression and purification:

• Transform expression plasmid into E. coli host strains

• Induce protein expression (typically with IPTG for T7-based systems)

• Lyse cells and purify using nickel affinity chromatography leveraging the His-tag

• Further purify by size exclusion chromatography if higher purity is required

• Lyophilize or store in appropriate buffer with cryoprotectants

The resulting purified protein can be stored as a lyophilized powder or in Tris/PBS-based buffer with 6% trehalose at pH 8.0 .

What are the optimal storage and handling conditions for recombinant plsY?

For optimal stability and activity of recombinant Salmonella dublin plsY:

Repeated freeze-thaw cycles should be strictly avoided as they can lead to protein denaturation and loss of enzymatic activity .

How can researchers verify the expression and activity of recombinant plsY?

Verification of recombinant plsY expression and activity should involve multiple approaches:

• Expression verification:

  • SDS-PAGE analysis to confirm protein size (expected ~23 kDa plus tag size)

  • Western blot using anti-His antibodies or specific anti-plsY antibodies

  • Mass spectrometry for precise identification

• Activity assessment:

  • Enzymatic assays measuring the transfer of acyl groups to glycerol-3-phosphate

  • Monitoring lysophosphatidic acid formation using thin-layer chromatography or HPLC

  • Coupled enzyme assays that detect products of the acyltransferase reaction

• Structural integrity:

  • Circular dichroism spectroscopy to assess secondary structure

  • Limited proteolysis to evaluate proper folding

  • Thermal shift assays to determine stability

Similar verification methods have been successfully applied to other recombinant proteins expressed in Salmonella systems, such as immunoblotting techniques used to detect secreted recombinant proteins in both cell lysates and culture supernatants .

What approaches can be used to study plsY's role in Salmonella dublin pathogenesis?

To investigate plsY's contribution to Salmonella dublin pathogenesis:

• Gene knockout/knockdown studies:

  • CRISPR-Cas9 gene editing to create plsY deletion mutants

  • Inducible antisense RNA to create conditional knockdowns

  • Complementation studies to confirm phenotype specificity

• Virulence assessment:

  • Animal infection models (e.g., calf models for Salmonella dublin)

  • Cell invasion assays using relevant host cell types

  • Bacterial survival in macrophages or other immune cells

  • Competitive index experiments comparing wild-type and plsY mutants

• Membrane integrity analysis:

  • Phospholipid composition analysis by mass spectrometry

  • Membrane permeability assays

  • Antibiotic susceptibility profiling

• Host-pathogen interaction studies:

  • Immunofluorescence microscopy to track bacterial localization

  • Transcriptomics to assess host response to wild-type vs. plsY mutants

  • Metabolomics to identify altered metabolic pathways

Such approaches would build upon established methodologies used in studying other Salmonella dublin virulence factors, including those examined in attenuated strains like SL5631 .

What are common challenges in expressing and purifying active recombinant plsY?

Researchers frequently encounter several challenges when working with recombinant plsY:

How can researchers distinguish between native and recombinant plsY activity in experimental systems?

Differentiating native from recombinant plsY activity requires careful experimental design:

• Tagging strategies:

  • Use epitope tags (His, FLAG, HA) on recombinant plsY that allow specific detection

  • Develop tag-specific activity assays that selectively measure recombinant enzyme

• Expression control:

  • Use inducible promoters to control recombinant plsY expression

  • Compare activity before and after induction

  • Quantify expression levels by Western blot to correlate with activity

• Selective inhibition:

  • Design inhibitors specific to recombinant plsY (e.g., tag-binding inhibitors)

  • Use genetic approaches to selectively inhibit native or recombinant plsY

• Kinetic discrimination:

  • Characterize and compare kinetic parameters of native and recombinant enzymes

  • Identify substrate concentration ranges where one form predominates

  • Use modified substrates that preferentially interact with one form

• Background elimination:

  • Express recombinant plsY in plsY-knockout backgrounds

  • Use heterologous expression systems lacking endogenous plsY activity

What are the implications of plsY sequence variations across different Salmonella strains?

Sequence variations in plsY across Salmonella strains can have significant implications:

• Functional consequences:

  • Altered substrate specificity affecting phospholipid composition

  • Changes in enzyme efficiency impacting membrane biosynthesis rates

  • Modified regulation of enzyme activity

  • Variations in protein stability and cellular localization

• Evolutionary significance:

  • Insights into adaptation to different host environments

  • Understanding selective pressures on membrane composition

  • Identification of conserved catalytic residues versus variable regions

• Experimental design considerations:

  • Strain-specific optimization of expression and purification protocols

  • Need for strain-specific activity assays and antibodies

  • Caution when extrapolating findings between strains

• Therapeutic targeting:

  • Identification of conserved regions as broad-spectrum targets

  • Strain-specific inhibitor design for targeted interventions

  • Potential for resistance development through sequence variation

Researchers should conduct thorough sequence alignment analysis of plsY across Salmonella strains to identify conserved domains and variable regions before designing experiments or interpreting results across strains.

How can plsY be leveraged as a potential antimicrobial target?

Glycerol-3-phosphate acyltransferase (plsY) represents a promising antimicrobial target for several reasons:

• Essential metabolic function:

  • plsY catalyzes a critical step in phospholipid biosynthesis required for bacterial membrane formation

  • Gene knockout studies in related bacteria suggest plsY is essential for viability

• Target validation approaches:

  • Conditional knockdowns to demonstrate growth inhibition

  • Gene essentiality studies across growth conditions

  • In vivo validation using animal infection models

• Inhibitor development strategies:

  • High-throughput screening of compound libraries against purified recombinant plsY

  • Structure-based drug design utilizing crystallographic data

  • Fragment-based approaches to identify binding scaffolds

  • Natural product screening for novel inhibitory scaffolds

• Combination therapy potential:

  • Synergy testing with existing antibiotics

  • Membrane permeabilization to enhance uptake of other antimicrobials

  • Multi-target approaches hitting different steps in phospholipid synthesis

• Resistance mitigation:

  • Target highly conserved catalytic residues to minimize resistance development

  • Develop dual-targeting inhibitors affecting multiple steps in the same pathway

  • Design peptidomimetics that mimic essential protein-protein interactions

What methodologies are most effective for analyzing plsY interactions with other proteins in the phospholipid synthesis pathway?

To effectively study plsY interactions with other components of the phospholipid synthesis pathway:

• In vitro interaction analyses:

  • Pull-down assays using purified recombinant plsY with His-tag

  • Surface plasmon resonance to determine binding kinetics

  • Isothermal titration calorimetry for thermodynamic parameters

  • Crosslinking coupled with mass spectrometry for interaction mapping

• Structural biology approaches:

  • X-ray crystallography of plsY in complex with interaction partners

  • Cryo-electron microscopy for larger complexes

  • NMR spectroscopy for mapping interaction interfaces

  • Hydrogen-deuterium exchange mass spectrometry to identify binding regions

• Cellular interaction studies:

  • Bacterial two-hybrid systems

  • Fluorescence resonance energy transfer (FRET)

  • Split-GFP complementation assays

  • Co-immunoprecipitation from bacterial lysates

  • Proximity labeling methods (BioID, APEX)

• Systems biology approaches:

  • Protein correlation profiling

  • Genetic interaction mapping through synthetic lethality screens

  • Metabolic flux analysis to assess functional interactions

• Computational methods:

  • Molecular docking simulations

  • Protein-protein interaction prediction algorithms

  • Metabolic network modeling

  • Evolutionary coupling analysis

How can researchers effectively compare plsY function between pathogenic and non-pathogenic Salmonella strains?

To systematically compare plsY function across pathogenic and non-pathogenic Salmonella strains:

• Comparative genomics approach:

  • Sequence alignment and phylogenetic analysis of plsY across strains

  • Identification of single nucleotide polymorphisms and their predicted functional impact

  • Analysis of genomic context and operon structure

  • Assessment of selection pressure through dN/dS ratios

• Biochemical characterization:

  • Side-by-side enzymatic assays of purified recombinant plsY from different strains

  • Determination of enzyme kinetics (Km, Vmax, catalytic efficiency)

  • Substrate specificity profiling

  • Inhibitor sensitivity comparison

  • Thermal and pH stability analyses

• Functional complementation studies:

  • Cross-complementation of plsY knockouts between strains

  • Phenotypic rescue assessment under various stress conditions

  • Construction of chimeric plsY variants to map functional domains

• Membrane biology comparisons:

  • Lipidomic analysis of membrane composition

  • Membrane fluidity measurements

  • Antibiotic permeability assays

  • Stress resistance profiling (osmotic, pH, temperature)

• Host-pathogen interaction experiments:

  • Virulence assessment in infection models

  • Survival within macrophages

  • Inflammatory response elicitation

  • Immune evasion capabilities

These approaches build upon established methodologies in bacterial genetics and protein biochemistry, such as those used to study other bacterial proteins expressed in Salmonella dublin systems .

What statistical approaches are most appropriate for analyzing plsY enzymatic activity data?

When analyzing plsY enzymatic activity data, researchers should consider these statistical approaches:

For all analyses, researchers should:

• Perform power analysis to determine appropriate sample sizes

• Include proper biological and technical replicates

• Validate statistical assumptions (normality, homoscedasticity)

• Report effect sizes alongside p-values

• Consider Bayesian approaches for small sample sizes

How can researchers effectively integrate plsY structural data with functional analyses?

Integrating structural and functional data for plsY requires a multidisciplinary approach:

• Structure-guided mutagenesis:

  • Identify conserved or functionally important residues through structural analysis

  • Generate site-directed mutants of key residues

  • Perform functional assays on mutants to correlate structure with activity

  • Create a comprehensive structure-function map

• Molecular dynamics simulations:

  • Simulate plsY behavior in membrane environments

  • Analyze substrate binding and product release pathways

  • Identify conformational changes during catalytic cycle

  • Predict effects of mutations or ligand binding

• Integrative visualization:

  • Map enzymatic activity data onto structural models

  • Visualize evolutionary conservation in structural context

  • Highlight protein-protein interaction interfaces

  • Correlate thermal stability data with structural features

• Structure-based inhibitor design:

  • Utilize active site geometry for rational inhibitor design

  • Perform virtual screening against structural pockets

  • Validate binding modes through crystallography or NMR

  • Iteratively improve inhibitors based on structural feedback

• Comprehensive databases:

  • Develop relational databases linking sequence, structure, and functional data

  • Create visual interfaces for data exploration

  • Implement machine learning to predict function from structure

  • Enable collaborative annotation and analysis

This integration provides a more complete understanding of how plsY's three-dimensional structure enables its role in phospholipid biosynthesis and potentially informs therapeutic targeting strategies.

What are the key considerations when designing experiments to assess plsY's role in antibiotic resistance?

When investigating plsY's potential role in antibiotic resistance, researchers should consider:

• Experimental design framework:

  • Compare plsY expression levels between resistant and susceptible strains

  • Generate plsY overexpression and knockdown models to assess impact on resistance

  • Perform complementation studies in resistant mutants

  • Conduct time-kill kinetics under various antibiotic pressures

• Membrane-specific considerations:

  • Analyze changes in membrane phospholipid composition

  • Assess membrane permeability using fluorescent dyes

  • Measure changes in membrane potential

  • Quantify antibiotic accumulation within cells

• Resistance mechanism investigation:

  • Determine if plsY alterations modify drug target accessibility

  • Assess impact on efflux pump efficiency

  • Investigate potential metabolic adaptations affecting resistance

  • Examine changes in cell wall integrity

• Clinical relevance assessment:

  • Analyze plsY sequences in clinical isolates with varying resistance profiles

  • Correlate plsY polymorphisms with minimum inhibitory concentrations

  • Test efficacy of combination therapies targeting plsY and established mechanisms

  • Evaluate fitness costs of resistance-associated plsY mutations

• Controls and validation:

  • Include appropriate susceptible and resistant reference strains

  • Verify that observed effects are specific to plsY (not polar effects)

  • Test multiple antibiotics representing different classes

  • Confirm findings across multiple Salmonella strains

These approaches build upon established methodologies used to study other bacterial components involved in antibiotic resistance and membrane biosynthesis pathways.